ACLA News
-
Op-Ed: If Washington takes a short-sighted view, seniors will pay the price
This week, ACLA President Julie Khani published an op-ed in The Hill, responding to a troubling recent proposal by Roger Klein to disregard private payor data and instead impose a spending cap for some tests. As Khani points out, “Such a plan would further erode PAMA’s clear goal of moving to a market-based system in Medicare and would undermine the assurances of a predictableContinue Reading »... -
New Report Highlights Value of Clinical Labs to U.S. Economy
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today released new economic data highlighting the contributions of clinical laboratories to the economy and the job market in the United States. The findings provide a snapshot of the benefits clinical labs provide to the national economy as well as states and local communities. Clinical laboratories support more than 688,000 jobs in the workforce, bringingContinue Reading »... -
More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers reiterated the urgent need for Congressional action on a modernized regulatory framework for clinical laboratory diagnostics. Patients have yet to benefit from groundbreaking clinical diagnostics that monitor and support treatment for complex and rareContinue Reading »... -
ACLA Expands Policy, Government Affairs Teams with Joan Kegerize, Liz Thomas
Kegerize to help lead ACLA’s policy work related to reimbursement & scientific affairs; Thomas to support industry’s broader advocacy and federal affairs priorities Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced two new additions to the Association’s policy and advocacy teams. Joan Kegerize, who previously served as a principal consultant for GMBI Consulting, will serve as Vice President of Reimbursement andContinue Reading »... -
ACLA Appellant/Petitioner Brief: American Clinical Laboratory Association v. Alex Azar
... -
ACLA Urges Congressional Leaders to Advance New Regulatory Framework for Diagnostic Tests
In Comments to Congress, ACLA Cites Concerns with the FDA’s New Proposals for Diagnostic Reform Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) calls on Congressional leaders to enact a distinct regulatory framework for diagnostics – a key goal outlined in comments to Reps. Larry Bucshon (R-IN) and Diana DeGette (D-CO), and Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO). The commentsContinue Reading »... -
Stakeholder Letter on Diagnostic Reform
... -
ACLA Urges Summary Judgment from District Court on Lawsuit Against HHS
Lawsuit targets HHS’ unlawful implementation of 2014 Medicare legislation, regulation that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – With millions of Medicare beneficiaries facing potential shortages in critical laboratory tests and diagnostics, the American Clinical Laboratory Association (ACLA) continued the push for summary judgment in its lawsuit against the U.S. Department of Health and Human Services (HHS) for failing toContinue Reading »... -
ACLA VS. AZAR – Reply in Support of Motion for Summary Judgment
... -
ACLA Supportive of CMS Revisions to National Coverage Determination on the Use of Next Generation Sequencing in Cancer
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) expressed support today for revisions made by the Centers for Medicare and Medicaid Services (CMS) to the final National Coverage Determination (NCD) released today on Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer. The association and other stakeholders submitted extensive comments to the agency on the proposed NCD to ensure that the policyContinue Reading »...
